Skip subpage navigation
Meningococcal disease can refer to any illness that is caused by the type of bacteria called Neisseria meningitides. These illnesses are often severe and include infections of the lining of the brain and spinal cord (meningitis) and bloodstream infections (bacteremia or septicemia).
Meningococcus bacteria are spread through the exchange of respiratory and throat secretions like spit (e.g., by living in close quarters, kissing). Meningococcal disease can be treated with antibiotics, but quick medical attention is extremely important.
Keeping up to date with recommended vaccines is the best defense against meningococcal disease. Vaccines are now available that help protect against five serogroups of meningococcal disease (A, B, C, W and Y) most commonly seen in the United States.
The vaccines that protect against serogroups A, C, W and Y are recommended for infants and children at high risk for disease by these four serogroups and routinely for adolescents ages 11 through 18. The serogroup B meningococcal vaccines are recommended for those 10 and older who are at increased risk for serogroup B infection and for individuals 16 through 23 years of age, on the basis of shared clinical decision-making, to protect against serogroup B meningococcal disease in certain settings.
Source: Centers for Disease Control and Prevention
You will find below all of the resources you will need about the meningococcal vaccine. More will be added as they are published or released.
| Information Paper |
Date |
| Meningococcal Disease and Meningococcal Vaccine |
Nov. 29, 2023 |
| Standing Orders |
Date |
| Meningococcal ACWY Vaccine (Pediatric)
|
July 25, 2024 |
| Meningococcal ACWY Vaccine (Adult) |
May 24, 2024 |
| Meningococcal B Vaccine (Pediatric) |
May 24, 2024 |
Meningococcal B Vaccine (Adult)
|
May 24, 2024 |
| Vaccine Information Statements |
Date |
Meningococcal ACWY Vaccines — MenACWY and MPSV4: What You Need to Know
|
Aug. 6, 2021 |
Serogroup B Meningococcal Vaccine (MenB): What You Need to Know
|
Aug. 6, 2021 |
| Manufacturer Package Inserts |
Date |
Bexsero (B)
|
Aug. 19, 2024 |
Trumenba (B)
|
June 18, 2024 |
MenQuadfi
|
Sept. 20, 2024 |
Menveo
|
Aug. 30, 2024 |
Penbraya (ABCWY)
|
Sept. 9, 2024 |
| Advisory Committee on Immunization Practices Recommendations |
Date |
Meningococcal Vaccine
|
April 18, 2024 |
You also may be interested in...
Fact Sheet
Nov 29, 2023
.PDF |
162.72 KB
This information paper describes meningococcal disease and the vaccines to prevent it.
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: October 28, 2024